The data is big,please wait a moment......
| EWAS ID | KEGG ID | Class | Disease/Phenotype [sample size n] |
Sample groups (case/control, trait, cell type etc.) |
KEGG Pathway Name | Pathway Gene Number | Gene Number Annotated In The KEGG Pathway | Pvalue | |
| Group1 [sample size n] |
Group2 [sample size n] |
||||||||
| EWAS140 | hsa00051 | disease | atherosclerosis [n=31] |
Atherosclerotic lesion [n=15] |
Aortic tissue [n=15] |
Fructose and mannose metabolism | 32 | 28 | 0.000304 |
| EWAS140 | hsa00410 | disease | atherosclerosis [n=31] |
Atherosclerotic lesion [n=15] |
Aortic tissue [n=15] |
beta-Alanine metabolism | 30 | 26 | 0.000656 |
| EWAS140 | hsa00514 | disease | atherosclerosis [n=31] |
Atherosclerotic lesion [n=15] |
Aortic tissue [n=15] |
Other types of O-glycan biosynthesis | 30 | 27 | 0.000107 |
| EWAS140 | hsa00533 | disease | atherosclerosis [n=31] |
Atherosclerotic lesion [n=15] |
Aortic tissue [n=15] |
Glycosaminoglycan biosynthesis - keratan sulfate | 15 | 15 | 0 |
| EWAS140 | hsa00601 | disease | atherosclerosis [n=31] |
Atherosclerotic lesion [n=15] |
Aortic tissue [n=15] |
Glycosphingolipid biosynthesis - lacto and neolacto series | 26 | 24 | 6.72e-005 |
| EWAS140 | hsa04010 | disease | atherosclerosis [n=31] |
Atherosclerotic lesion [n=15] |
Aortic tissue [n=15] |
MAPK signaling pathway | 251 | 193 | 1.43e-007 |
| EWAS140 | hsa04012 | disease | atherosclerosis [n=31] |
Atherosclerotic lesion [n=15] |
Aortic tissue [n=15] |
ErbB signaling pathway | 87 | 68 | 0.000405 |
| EWAS140 | hsa04014 | disease | atherosclerosis [n=31] |
Atherosclerotic lesion [n=15] |
Aortic tissue [n=15] |
Ras signaling pathway | 226 | 176 | 9.52e-008 |
| EWAS140 | hsa04015 | disease | atherosclerosis [n=31] |
Atherosclerotic lesion [n=15] |
Aortic tissue [n=15] |
Rap1 signaling pathway | 211 | 179 | 5.84e-014 |
| EWAS140 | hsa04020 | disease | atherosclerosis [n=31] |
Atherosclerotic lesion [n=15] |
Aortic tissue [n=15] |
Calcium signaling pathway | 178 | 149 | 5.36e-011 |